MS4A6E Inhibitors
MS4A6E inhibitors encompass a range of compounds that indirectly affect the activity of MS4A6E through various biochemical and cellular mechanisms. For example, compounds such as Epigallocatechin gallate (EGCG) and Curcumin exert their inhibitory effects by modulating the NF-κB signaling pathway, a known regulator of gene expression, including that of MS4A6E. By inhibiting this pathway, these compounds can reduce MS4A6E transcription and subsequent protein levels.
Another approach to inhibiting MS4A6E is by impacting the cell's signaling and energy status. Compounds like LY294002, Rapamycin, and Niclosamide disrupt crucial intracellular signaling pathways (PI3K/AKT, mTOR) and energy production processes (oxidative phosphorylation), respectively. Disruption of these pathways can lead to a decrease in the overall functional activity of MS4A6E by altering the cellular conditions necessary for its optimal function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea inhibits ribonucleotide reductase, leading to a decrease in deoxyribonucleotide triphosphates (dNTPs). MS4A6E expression is dependent on the cell cycle, and by reducing dNTPs, hydroxyurea can slow or arrest cell cycle progression, thereby indirectly inhibiting MS4A6E expression. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can lead to the activation of downstream signaling pathways that affect cellular differentiation and proliferation. By promoting these pathways, PMA could alter the cellular context in which MS4A6E operates, potentially reducing its functional activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. By broadly inhibiting kinase activity, it can disrupt multiple signaling pathways, some of which may be necessary for the optimal activity of MS4A6E, therefore indirectly leading to its functional inhibition. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, which are upstream of ERK in the MAPK pathway. Inhibition of the MAPK pathway could alter transcription factor activity and gene expression profiles, including those that regulate MS4A6E function, leading to its downregulation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits phosphoinositide 3-kinases (PI3K), which are involved in the AKT signaling pathway. This pathway is linked to cellular survival and proliferation, and its inhibition can reduce the expression and functional activity of proteins like MS4A6E that are associated with these processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which plays a central role in cell growth and metabolism. Inhibition of mTOR can lead to reduced protein synthesis and cell proliferation, processes in which MS4A6E may be involved, thereby decreasing its functional activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that can dampen inflammatory responses and other p38-dependent signaling pathways. Since MS4A6E may be expressed in inflammatory contexts, inhibition of p38 MAPK can indirectly reduce MS4A6E functional activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which indirectly leads to inhibition of ERK phosphorylation within the MAPK pathway. This can alter gene expression and cellular functions that rely on this pathway, potentially inhibiting MS4A6E activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor, which impacts cellular processes such as apoptosis and cell proliferation. By inhibiting JNK, this compound could indirectly reduce the functional activity of MS4A6E, which may be regulated by stress response pathways. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to the depletion of ER calcium stores and induces ER stress. Prolonged ER stress can downregulate protein synthesis and potentially inhibit proteins like MS4A6E that are dependent on proper cell function. | ||||||